{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:27:27Z","timestamp":1786994847185,"version":"build-2736575974"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006778","name":"Georgia Institute of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006778","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["1 R01 EY023173"],"award-info":[{"award-number":["1 R01 EY023173"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01DA029639"],"award-info":[{"award-number":["R01DA029639"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["1-U01-MH106027-01"],"award-info":[{"award-number":["1-U01-MH106027-01"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01NS102727"],"award-info":[{"award-number":["R01NS102727"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015620","name":"Institute for Bioengineering and Biosciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015620","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.neurobiolaging.2026.05.005","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:15:12Z","timestamp":1778825712000},"page":"41-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Regional alterations of parvalbumin interneurons in human App knock-in mouse model of Alzheimer\u2019s disease pathology"],"prefix":"10.1016","volume":"166","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8620-6020","authenticated-orcid":false,"given":"Mercedes M.","family":"Gonzalez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Magondu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.M.","family":"Rowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig R.","family":"Forest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2026.05.005_b1","first-page":"1","article-title":"Impaired spike-gamma coupling of area CA3 fast-spiking interneurons as the earliest functional impairment in the AppNL-G-F mouse model of Alzheimer\u2019s disease","author":"Arroyo-Garcia","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-017-0228-2","article-title":"Abnormal dendritic calcium activity and synaptic depotentiation occur early in a mouse model of Alzheimer\u2019s disease","volume":"12","author":"Bai","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b3","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.neuron.2019.01.056","article-title":"A quarter century of APOE and Alzheimer\u2019s disease: Progress to date and the path forward","volume":"101","author":"Belloy","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jalz.2012.01.011","article-title":"Alzheimer\u2019s disease: Pathogenesis and prevention","volume":"8","author":"Braak","year":"2012","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b6","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25245789","article-title":"Comprehensive review on Alzheimer\u2019s disease: Causes and treatment","volume":"25","author":"Breijyeh","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b7","doi-asserted-by":"crossref","first-page":"8740","DOI":"10.1073\/pnas.1206171109","article-title":"Critical role of soluble amyloid-\u03b2 for early hippocampal hyperactivity in a mouse model of Alzheimer\u2019s disease","volume":"109","author":"Busche","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b8","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1126\/science.1162844","article-title":"Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer\u2019s disease","volume":"321","author":"Busche","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b9","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1038\/nn.4163","article-title":"Decreased amyloid-\u03b2 and increased neuronal hyperactivity by immunotherapy in Alzheimer\u2019s models","volume":"18","author":"Busche","year":"2015","journal-title":"Nature Neurosci."},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b10","first-page":"210","article-title":"Alternative hypotheses related to Alzheimer\u2019s disease","volume":"119","author":"Cubinkova","year":"2018","journal-title":"Bratisl. Lek. List."},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.neurobiolaging.2014.07.001","article-title":"Entorhinal cortical defects in Tg2576 mice are present as early as 2\u20134 months of age","volume":"36","author":"Duffy","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b12","doi-asserted-by":"crossref","first-page":"7918","DOI":"10.1038\/s41467-024-52297-3","article-title":"Entorhinal cortex vulnerability to human APP expression promotes hyperexcitability and tau pathology","volume":"15","author":"Goettemoeller","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b13","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1523\/JNEUROSCI.16-14-04491.1996","article-title":"Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer\u2019s disease","volume":"16","author":"Gomez-Isla","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b14","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.isci.2018.10.014","article-title":"Balanced activity between Kv3 and nav channels determines fast-spiking in mammalian cent. Neurons","volume":"9","author":"Gu","year":"2018","journal-title":"IScience"},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ana.25406","article-title":"Longitudinal tau accumulation and atrophy in aging and Alzheimer disease","volume":"85","author":"Harrison","year":"2019","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b16","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1038\/s41380-019-0483-4","article-title":"Early restoration of parvalbumin interneuron activity prevents memory loss and network hyperexcitability in a mouse model of Alzheimer\u2019s disease","volume":"25","author":"Hijazi","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b17","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1056\/NEJMsa1204629","article-title":"Monetary costs of dementia in the United States","volume":"368","author":"Hurd","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b18","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.tins.2022.11.006","article-title":"Entorhinal cortex dysfunction in Alzheimer\u2019s disease","volume":"46","author":"Igarashi","year":"2023","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b19","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1402573","article-title":"Impairment of entorhinal cortex network activity in Alzheimer\u2019s disease","volume":"16","author":"Karimani","year":"2024","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b20","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/nn.3606","article-title":"Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer\u2019s disease","volume":"17","author":"Khan","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3233\/JAD-215699","article-title":"Alzheimer\u2019s disease: Key insights from two decades of clinical trial failures","volume":"87","author":"Kim","year":"2022","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b22","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b23","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.nbd.2016.05.012","article-title":"Reelin-immunoreactive neurons in entorhinal cortex layer II selectively express intracellular amyloid in early Alzheimer\u2019s disease","volume":"93","author":"Kobro-Flatmoen","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b24","article-title":"Method for rapid enzymatic cleaning for reuse of patch clamp pipettes","author":"Landry","year":"2020","journal-title":"Bio-Protoc."},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b25","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13195-021-00859-8","article-title":"Reversible GABAergic dysfunction involved in hippocampal hyperactivity predicts early-stage Alzheimer disease in a mouse model","volume":"13","author":"Li","year":"2021","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b26","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.cub.2016.01.070","article-title":"Selective persistence of sensorimotor mismatch signals in visual cortex of behaving Alzheimer\u2019s disease mice","volume":"26","author":"Liebscher","year":"2016","journal-title":"Curr. Biol."},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/35044552","article-title":"Dendritic integration of excitatory synaptic input","volume":"1","author":"Magee","year":"2000","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.33594\/000000397","article-title":"The amyloid precursor protein C99 fragment modulates voltage-gated potassium channels","volume":"55","author":"Manville","year":"2021","journal-title":"Cell. Physiol. Biochem.: Int. J. Exp. Cell. Physiol. Biochem. Pharm."},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b29","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2018.02.029","article-title":"Nav1.1-overexpressing interneuron transplants restore brain rhythms and cognition in a mouse model of Alzheimer\u2019s disease","author":"Martinez-Losa","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b30","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/s41586-024-07606-7","article-title":"Single-cell multiregion dissection of Alzheimer\u2019s disease","volume":"632","author":"Mathys","year":"2024","journal-title":"Nat."},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0319397","article-title":"Retinal and thalamic alterations in the 5xFAD mouse model of Alzheimer\u2019s disease","volume":"20","author":"McCool","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b32","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0896-6273(03)00200-9","article-title":"Shunting inhibition modulates neuronal gain during synaptic excitation","volume":"38","author":"Mitchell","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b33","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00401-019-02054-4","article-title":"The basis of cellular and regional vulnerability in Alzheimer\u2019s disease","volume":"138","author":"Mrdjen","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b34","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1038\/s41467-017-01444-0","article-title":"Neuronal hyperactivity due to loss of inhibitory tone in APOE4 mice lacking Alzheimer\u2019s disease-like pathology","volume":"8","author":"Nuriel","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b35","article-title":"Biophysical KV channel alterations dampen excitability of cortical PV interneurons and contribute to network hyperexcitability in early Alzheimer\u2019s","volume":"2021.10.25.465789","author":"Olah","year":"2021","journal-title":"ELife"},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b36","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/cercor\/bhz016","article-title":"Aberrant excitatory\u2013Inhibitory synaptic mechanisms in entorhinal cortex microcircuits during the pathogenesis of Alzheimer\u2019s disease","volume":"29","author":"Petrache","year":"2019","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b37","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nn.3697","article-title":"Single app knock-in mouse models of Alzheimer\u2019s disease","volume":"17","author":"Saito","year":"2014","journal-title":"Nature Neurosci."},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b38","doi-asserted-by":"crossref","first-page":"E2895","DOI":"10.1073\/pnas.1121081109","article-title":"Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer\u2019s disease model","volume":"109","author":"Sanchez","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b39","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1093\/cercor\/bhl030","article-title":"Hippocampal and neocortical gamma oscillations predict memory formation in humans","volume":"17","author":"Sederberg","year":"2007","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b40","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1523\/JNEUROSCI.2880-19.2020","article-title":"Selective disruption of inhibitory synapses leading to neuronal hyperexcitability at an early stage of tau pathogenesis in a mouse model","volume":"40","author":"Shimojo","year":"2020","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b41","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"Jama"},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0233700","article-title":"Amyloid \u03b2 induces interneuron-specific changes in the hippocampus of APPNL-f mice","volume":"15","author":"Sos","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105557","article-title":"Synapse vulnerability and resilience underlying Alzheimer\u2019s disease","volume":"112","author":"Taddei","year":"2025","journal-title":"EBioMed"},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b44","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41398-022-02024-7","article-title":"Neuronal hyperexcitability in Alzheimer\u2019s disease: What are the drivers behind this aberrant phenotype?","volume":"12","author":"Targa Dias Anastacio","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b45","doi-asserted-by":"crossref","first-page":"8979","DOI":"10.1002\/alz.14258","article-title":"Retrosplenial hypometabolism precedes the conversion from mild cognitive impairment to Alzheimer\u2019s disease","volume":"20","author":"Terstege","year":"2024","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b46","doi-asserted-by":"crossref","first-page":"eadt8976","DOI":"10.1126\/sciadv.adt8976","article-title":"Impaired parvalbumin interneurons in the retrosplenial cortex as the cause of sex-dependent vulnerability in Alzheimer\u2019s disease","volume":"11","author":"Terstege","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b47","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of A\u03b2-deposition in the human brain and its relevance for the development of AD","volume":"58","author":"Thal","year":"2002","journal-title":"Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b48","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"Van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b49","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.cell.2012.02.046","article-title":"Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model","volume":"149","author":"Verret","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b50","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1001\/jamaneurol.2021.3310","article-title":"Effect of levetiracetam on cognition in patients with alzheimer disease with and without epileptiform activity: A randomized clinical trial","volume":"78","author":"Vossel","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b51","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/ana.24794","article-title":"Incidence and impact of subclinical epileptiform activity in Alzheimer\u2019s disease","volume":"80","author":"Vossel","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2026.05.005_b52","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-022-00547-7","article-title":"Novel app knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia","volume":"17","author":"Xia","year":"2022","journal-title":"Mol. Neurodegener."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458026000898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458026000898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:24:02Z","timestamp":1783124642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458026000898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":52,"alternative-id":["S0197458026000898"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2026.05.005","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regional alterations of parvalbumin interneurons in human App knock-in mouse model of Alzheimer\u2019s disease pathology","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2026.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}